4.5 Article

Experiences of symptoms in men with hormone refractory prostate cancer and skeletal metastases

Journal

EUROPEAN JOURNAL OF ONCOLOGY NURSING
Volume 12, Issue 4, Pages 283-290

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ejon.2008.03.003

Keywords

Fatigue; Hormone refractory prostatic neoplasm; Pain; Skeletal metastases; Symptoms; Quality of life; Questionnaires and interviews

Funding

  1. Lion's Cancer Research Foundation at Umea University,
  2. Cancer Research Foundation in Northern Sweden,
  3. Swedish Cancer Society
  4. Vasterbotten County Council

Ask authors/readers for more resources

Advanced prostate cancer with skeletal metastases entails significant symptoms from both treatment and the disease itself. Although the diagnosis is a common one, knowledge of the symptom experience late in the disease trajectory is limited. The aim of the present study was to describe the experience of physical symptoms in men with hormone refractory prostate cancer and skeletal metastases. Twenty men answered a quality of life questionnaire before participating in semi-structured interviews. The interviews were analyzed using qualitative description. Findings show that the dominant symptoms were lack of energy and pain. Interestingly when talking about lacking energy the men described three different variants; lack of mental energy or initiative, lack of strength and stamina, and tiredness or sleepiness. Also, three different types of pain were described; pain from skeletal metastases, a diffuse moving pain, and pain not directly caused by the prostate cancer. Though a majority of the men scored being dissatisfied with their sex life; in the interviews, this was not described as a major distress. The findings also showed that the men experienced different symptoms despite the same diagnosis, skeletal metastases, stage, and androgen deprivation treatment, and that these symptoms are not necessarily experienced as problems or causing distress. (c) 2008 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available